<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Skinframe Articles</title>
    <link>https://skinframe.app/articles/</link>
    <description>A photo-first rosacea tracker built around current dermatology consensus.</description>
    <language>en-US</language>
    <lastBuildDate>Thu, 04 Jun 2026 16:00:12 GMT</lastBuildDate>
    <managingEditor>support@sailquery.com (Skinframe)</managingEditor>
    <atom:link href="https://skinframe.app/rss.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>16 million Americans have rosacea. The tracker category they need has been left structurally underbuilt.</title>
      <link>https://skinframe.app/articles/16m-rosacea-tracking-category/</link>
      <guid isPermaLink="true">https://skinframe.app/articles/16m-rosacea-tracking-category/</guid>
      <pubDate>Thu, 28 May 2026 18:29:45 GMT</pubDate>
      <description>Roughly 16 million Americans have rosacea. The category for tools that help them track it is one of the largest underbuilt niches in consumer health software. The published critiques converge on a small set of structural failures: phenotype-incorrect onboarding, collapsed severity scoring, ignored ocular phenotype, no skin-tone-equity work, and photo pipelines that fail serial comparability. This is the category-level argument for why a new entrant is worth building.</description>
      <category>Category Analysis</category>
    </item>
    <item>
      <title>The NRS 2002 trigger list is missing the largest new rosacea trigger of the decade.</title>
      <link>https://skinframe.app/articles/post-covid-rosacea-wave/</link>
      <guid isPermaLink="true">https://skinframe.app/articles/post-covid-rosacea-wave/</guid>
      <pubDate>Thu, 28 May 2026 18:29:45 GMT</pubDate>
      <description>The canonical NRS 2002 trigger list is a great patient-survey dataset and it is also missing the largest single new rosacea-trigger event of the last decade. A 34 percent post-COVID exacerbation rate in one retrospective study and a 28.8 percent post-infection rate in a 2025 cross-sectional study describe a trigger pattern the 2002 framing has no field for.</description>
      <category>Triggers</category>
    </item>
    <item>
      <title>Auto white balance, flash on, free-aim framing: every camera default that ships in consumer apps is wrong for clinical skin photography.</title>
      <link>https://skinframe.app/articles/every-derm-app-fails-clinical-photography/</link>
      <guid isPermaLink="true">https://skinframe.app/articles/every-derm-app-fails-clinical-photography/</guid>
      <pubDate>Thu, 28 May 2026 18:29:44 GMT</pubDate>
      <description>Auto white balance is explicitly discouraged in serial clinical photography. Flash creates specular hotspots that destroy erythema scoring. Standardized lighting, manual white-balance lock, fixed distance, dark blue background for skin of color: these are not opinions. They are the published protocol. Almost no consumer dermatology app implements any of them. The result is a photo set you cannot serially compare.</description>
      <category>Methodology</category>
    </item>
    <item>
      <title>Most rosacea patients have an elevated mite population on their faces. Here&apos;s what dermatology has figured out.</title>
      <link>https://skinframe.app/articles/demodex-the-rosacea-factor/</link>
      <guid isPermaLink="true">https://skinframe.app/articles/demodex-the-rosacea-factor/</guid>
      <pubDate>Thu, 28 May 2026 18:29:44 GMT</pubDate>
      <description>Rosacea patients have roughly 4 times the Demodex mite density of healthy controls. Topical ivermectin, which kills the mites, reduces rosacea lesions in randomized trials. The mites are there, the treatment that targets them works, and the causal story is still being worked out. We are going to explain what the literature actually says and what it doesn&apos;t, in plain language, without recommending you do anything beyond bring this up with your dermatologist.</description>
      <category>Treatments</category>
    </item>
    <item>
      <title>Menopause sometimes makes rosacea better. The estrogen connection explains why.</title>
      <link>https://skinframe.app/articles/estrogen-protective-hypothesis/</link>
      <guid isPermaLink="true">https://skinframe.app/articles/estrogen-protective-hypothesis/</guid>
      <pubDate>Thu, 28 May 2026 18:29:44 GMT</pubDate>
      <description>Postmenopausal patients sometimes report their rosacea getting better, not worse, when the literature might predict the opposite. The Nurses&apos; Health Study II analysis on exogenous hormones found that menopausal hormone therapy and oral contraceptives are dose-responsively associated with increased incident rosacea risk. Both findings line up with an estrogen-modulated mechanism dermatology has been quietly working out for years.</description>
      <category>Triggers</category>
    </item>
    <item>
      <title>Red wine triggers acute flushing. White wine raises incident risk.</title>
      <link>https://skinframe.app/articles/red-wine-vs-white-wine/</link>
      <guid isPermaLink="true">https://skinframe.app/articles/red-wine-vs-white-wine/</guid>
      <pubDate>Thu, 28 May 2026 18:29:43 GMT</pubDate>
      <description>Two separate strands of rosacea-and-alcohol research disagree at first glance, then reconcile in a way that matters at a wedding dinner. The NRS 2010 acute-flushing survey put red wine far ahead of white as a trigger. The Li 2017 NHS cohort found white wine and liquor associated with incident rosacea risk and red wine, not statistically associated. The disagreement is real, and the two findings are about different things.</description>
      <category>Triggers</category>
    </item>
    <item>
      <title>Coffee isn&apos;t the rosacea trigger. The temperature of the drink is.</title>
      <link>https://skinframe.app/articles/its-the-temperature-not-the-caffeine/</link>
      <guid isPermaLink="true">https://skinframe.app/articles/its-the-temperature-not-the-caffeine/</guid>
      <pubDate>Thu, 28 May 2026 18:29:43 GMT</pubDate>
      <description>Most rosacea patients learn from forum lore that they have to give up coffee. The published evidence is the opposite. A case-control study found that 60°C water and 60°C coffee produced equivalent flushing, and both at 22°C did not. A 82,737-woman cohort showed caffeine intake is inversely associated with incident rosacea risk. The trigger is the heat, not the chemistry.</description>
      <category>Triggers</category>
    </item>
    <item>
      <title>Dermatologists want a one-page summary. They don&apos;t want your dashboard URL.</title>
      <link>https://skinframe.app/articles/what-dermatologists-actually-want/</link>
      <guid isPermaLink="true">https://skinframe.app/articles/what-dermatologists-actually-want/</guid>
      <pubDate>Thu, 28 May 2026 18:29:43 GMT</pubDate>
      <description>The published preferences are clear and the consumer-app category has mostly ignored them. Dermatologists want a single-page summary with the flare count, the top trigger co-occurrences, two photos, and the quality-of-life trend. They explicitly do not want 90 daily photos, a dashboard URL, or a pseudo-diagnostic score the patient pulled off an app. The 12-minute visit makes this concrete.</description>
      <category>Methodology</category>
    </item>
    <item>
      <title>Half to three-quarters of rosacea patients develop ocular involvement. Most trackers have nowhere to log it.</title>
      <link>https://skinframe.app/articles/your-rosacea-app-should-track-your-eyes/</link>
      <guid isPermaLink="true">https://skinframe.app/articles/your-rosacea-app-should-track-your-eyes/</guid>
      <pubDate>Thu, 28 May 2026 18:29:42 GMT</pubDate>
      <description>Ocular involvement affects 50 to 72 percent of cutaneous rosacea patients, and in a meaningful subset it shows up before the facial component does. The 2017 phenotype framework lists ocular manifestations as a major phenotype, on its own line, with diagnostic weight. Most rosacea trackers don&apos;t have a field for it.</description>
      <category>Methodology</category>
    </item>
    <item>
      <title>The single rosacea severity score is broken by design. The published literature on the IGA says so.</title>
      <link>https://skinframe.app/articles/every-rosacea-severity-score-feels-broken/</link>
      <guid isPermaLink="true">https://skinframe.app/articles/every-rosacea-severity-score-feels-broken/</guid>
      <pubDate>Thu, 28 May 2026 18:29:42 GMT</pubDate>
      <description>Patients complain that their tracker&apos;s single severity number doesn&apos;t reflect what their face is actually doing. It turns out that complaint matches a published critique of the Investigator Global Assessment scale that dermatology has been working with for years. The collapse-into-one-number problem is structural, not a UX bug.</description>
      <category>Methodology</category>
    </item>
    <item>
      <title>Rosacea is underdiagnosed on darker skin. The dermatology literature has named the mechanism. Most consumer tools haven&apos;t responded.</title>
      <link>https://skinframe.app/articles/rosacea-on-every-skin-tone/</link>
      <guid isPermaLink="true">https://skinframe.app/articles/rosacea-on-every-skin-tone/</guid>
      <pubDate>Thu, 28 May 2026 18:29:42 GMT</pubDate>
      <description>Reported rosacea prevalence in Fitzpatrick IV-V skin sits at roughly 6 to 8 percent of the rosacea-diagnosed population. The literature is explicit that a meaningful share of that gap is diagnostic masking, not biology. Telangiectasia is harder to see against pigmented skin, and the dermatology image-classification models trained to spot it perform 3 times worse on darker skin than on lighter. We built Skinframe to not make that mistake worse.</description>
      <category>Methodology</category>
    </item>
    <item>
      <title>Dermatology retired rosacea subtypes in 2017. Most tracker apps still ask which one you have.</title>
      <link>https://skinframe.app/articles/rosacea-apps-2017-update/</link>
      <guid isPermaLink="true">https://skinframe.app/articles/rosacea-apps-2017-update/</guid>
      <pubDate>Thu, 28 May 2026 18:29:05 GMT</pubDate>
      <description>In 2017, the dermatology field formally retired the four-subtype rosacea model and replaced it with a phenotype framework. Nine years later, every rosacea-named tracker on the App Store still opens with &quot;which type of rosacea do you have?&quot; That question has a name in the literature, and the literature has moved on.</description>
      <category>Methodology</category>
    </item>
  </channel>
</rss>